FY2027 EPS Estimates for W. R. Berkley Increased by Analyst

W. R. Berkley Co. (NYSE:WRB) – Analysts at Zacks Research raised their FY2027 earnings estimates for shares of W. R. Berkley in a report issued on Tuesday, April 1st. Zacks Research analyst T. De now expects that the insurance provider will post earnings per share of $4.94 for the year, up from their previous estimate of $4.93. The consensus estimate for W. R. Berkley’s current full-year earnings is $4.33 per share.

Several other analysts also recently issued reports on WRB. Royal Bank of Canada restated a “sector perform” rating and set a $63.00 price objective on shares of W. R. Berkley in a report on Tuesday, January 28th. Keefe, Bruyette & Woods upped their price target on shares of W. R. Berkley from $60.00 to $61.00 and gave the company a “market perform” rating in a research report on Tuesday, January 28th. Barclays lifted their price objective on shares of W. R. Berkley from $50.00 to $52.00 and gave the stock an “underweight” rating in a research report on Tuesday, January 28th. Wells Fargo & Company raised their target price on W. R. Berkley from $67.00 to $70.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 28th. Finally, Morgan Stanley began coverage on W. R. Berkley in a research report on Thursday, December 5th. They set an “equal weight” rating and a $65.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, W. R. Berkley currently has a consensus rating of “Hold” and a consensus target price of $64.21.

W. R. Berkley Stock Performance

Shares of NYSE WRB opened at $69.73 on Thursday. W. R. Berkley has a 52-week low of $50.73 and a 52-week high of $76.38. The stock has a market capitalization of $26.44 billion, a price-to-earnings ratio of 15.98, a PEG ratio of 1.56 and a beta of 0.40. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.34. The stock’s fifty day simple moving average is $62.37 and its 200 day simple moving average is $60.43.

W. R. Berkley (NYSE:WRB) last posted its quarterly earnings results on Monday, January 27th. The insurance provider reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.18. W. R. Berkley had a net margin of 12.88% and a return on equity of 20.83%.

W. R. Berkley Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 12th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.08 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.32 annualized dividend and a dividend yield of 0.46%. W. R. Berkley’s dividend payout ratio (DPR) is 7.34%.

Institutional Investors Weigh In On W. R. Berkley

Institutional investors and hedge funds have recently modified their holdings of the business. Optiver Holding B.V. lifted its position in shares of W. R. Berkley by 107.3% in the fourth quarter. Optiver Holding B.V. now owns 427 shares of the insurance provider’s stock worth $25,000 after buying an additional 221 shares during the last quarter. Whipplewood Advisors LLC acquired a new stake in W. R. Berkley in the 4th quarter worth approximately $35,000. Mpwm Advisory Solutions LLC bought a new stake in W. R. Berkley during the fourth quarter worth approximately $37,000. Catalyst Capital Advisors LLC acquired a new position in W. R. Berkley during the fourth quarter valued at approximately $42,000. Finally, Colonial Trust Co SC raised its position in shares of W. R. Berkley by 79.9% in the fourth quarter. Colonial Trust Co SC now owns 822 shares of the insurance provider’s stock valued at $48,000 after purchasing an additional 365 shares during the period. Institutional investors and hedge funds own 68.82% of the company’s stock.

W. R. Berkley Company Profile

W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.